ArticleNPJ precision oncology2024

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates.

Azra Ajkunic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.